MorphoSys (MOR) Short Interest Ratio & Short Volume

Short interest is the volume of MorphoSys shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 135,000 shares of MOR short. Learn More on MorphoSys' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MOR shares currently have a short interest ratio of 1.0. Learn More on MorphoSys's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of MorphoSys: Parallax Volatility Advisers L.P., and Centiva Capital LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

MorphoSys saw a decrease in short interest in July. As of July 15th, there was short interest totaling 135,000 shares, a decrease of 48.5% from the previous total of 262,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to MorphoSys: Vaxcyte, Inc. (8.85%), Qiagen (1.68%), Intra-Cellular Therapies, Inc. (1.64%), Roivant Sciences Ltd. (12.55%), Ascendis Pharma A/S (6.21%), Revolution Medicines, Inc. (9.61%), Lantheus Holdings, Inc. (6.73%), Nuvalent, Inc. (12.26%), Legend Biotech Co. (13.04%), Blueprint Medicines Co. (6.60%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.

Short selling MOR is an investing strategy that aims to generate trading profit from MorphoSys as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for MorphoSys occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MOR, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MOR, twice per month. The most recent reporting period available is July, 15 2024.